Hinge Health, Inc. Class A (HNGE)
NYSE:HNGE
HNGE Stock Chart & Stats
$38.98
-$1.41(-3.71%)
At close: 4:00 PM EDT
$38.98
-$1.41(-3.71%)
Day’s Range― - ―
52-Week Range$30.08 - $62.18
Previous Close$36.79
Volume525.07K
Average Volume (3M)1.10M
Market Cap
$3.07B
Enterprise Value$2.87B
Total Cash (Recent Filing)$363.86M
Total Debt (Recent Filing)$8.04M
Price to Earnings (P/E)―
Beta1.61
Next Earnings
May 07, 2026EPS Estimate
0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.49
Shares Outstanding55,816,216
10 Day Avg. Volume789,492
30 Day Avg. Volume1,098,932
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)9.72
Price to Sales (P/S)6.26
P/FCF Ratio21.54
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue4.88
Enterprise Value/Gross Profit6.13
Enterprise Value/Ebitda-5.45
Forecast
1Y Price Target
$59.50Price Target Upside52.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)1.94
Revenue Forecast (FY)$736.57M
Bulls Say, Bears Say
Bulls Say
AI-driven Scalability And MarginsAnalyst notes AI-enabled tools and automation are allowing the company to serve more members while keeping clinical team size stable, supporting margin expansion and improved unit economics.
Market PenetrationAnalyst highlights very low current market penetration, implying a large runway for new member acquisition and long-term revenue growth as expansion continues into employer and payer segments.
Partnerships And Sales MomentumAnalyst cites strong partnerships with major health plans and PBMs, together with record new contract wins and high client retention, as a durable go-to-market advantage that should drive continued sales growth.
Bears Say
Customer Mix And Yield SustainabilityAnalyst highlights a higher proportion of small and medium customers, which may make it harder to sustain yield improvements compared with relying on larger enterprise clients.
Pricing Model Transition RiskAnalyst indicates the shift toward a usage-based pricing model introduces uncertainty and has weighed on shares as investors question whether pricing will sustainably raise revenue per member.
Sector Sentiment And Valuation PressureAnalyst warns that a negative software market backdrop and investor fears about AI disruption have pressured the stock and could keep valuation depressed despite operational improvements.
Hinge Health, Inc. Class A News
HNGE FAQ
What was Hinge Health, Inc. Class A’s price range in the past 12 months?
Hinge Health, Inc. Class A lowest stock price was $30.08 and its highest was $62.18 in the past 12 months.
What is Hinge Health, Inc. Class A’s market cap?
Hinge Health, Inc. Class A’s market cap is $3.07B.
When is Hinge Health, Inc. Class A’s upcoming earnings report date?
Hinge Health, Inc. Class A’s upcoming earnings report date is May 07, 2026 which is in 31 days.
How were Hinge Health, Inc. Class A’s earnings last quarter?
Hinge Health, Inc. Class A released its earnings results on Feb 10, 2026. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.412 by $0.078.
Is Hinge Health, Inc. Class A overvalued?
According to Wall Street analysts Hinge Health, Inc. Class A’s price is currently Undervalued.
Does Hinge Health, Inc. Class A pay dividends?
Hinge Health, Inc. Class A does not currently pay dividends.
What is Hinge Health, Inc. Class A’s EPS estimate?
Hinge Health, Inc. Class A’s EPS estimate is 0.39.
How many shares outstanding does Hinge Health, Inc. Class A have?
Hinge Health, Inc. Class A has 55,816,216 shares outstanding.
What happened to Hinge Health, Inc. Class A’s price movement after its last earnings report?
Hinge Health, Inc. Class A reported an EPS of $0.49 in its last earnings report, beating expectations of $0.412. Following the earnings report the stock price went up 17.277%.
Which hedge fund is a major shareholder of Hinge Health, Inc. Class A?
Currently, no hedge funds are holding shares in HNGE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hinge Health, Inc. Class A Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$59.50 (52.64% Upside)
$59.50 (52.64% Upside)
Blogger Sentiment
Bullish
HNGE Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 3.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
-132.16%
Trailing 12-Months
Asset Growth
10.50%
Trailing 12-Months
Company Description
Hinge Health, Inc. Class A
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
HNGE Company Deck
HNGE Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong operational and financial momentum: robust revenue growth, high margins, exceptional free cash flow generation, meaningful AI-driven efficiency gains, high retention, and large commercial expansion (24.6M contracted lives). Management provided confident 2026 guidance while noting deliberate investments and conservatism (e.g., limited near-term revenue from Hinge Select and flat ASP assumptions). Key risks and watch items include slower guided growth in 2026 versus 2025, still-low engagement yield relative to long-term benchmarks, delayed monetization of Hinge Select, and potentially confusing buyback disclosures that reduced cash. Overall, positive execution and durability of the business were the dominant themes, with a few strategic and timing-related caveats to monitor.View all HNGE earnings summariesHNGE Stock 12 Month Forecast
Average Price Target
$59.50
▲(52.64% Upside)
Technical Analysis
Eterna Therapeutics
―
MSP Recovery
―
Bluejay Diagnostics
―
Tivic Health Systems
―
Heart Test Laboratories, Inc.
―
Ownership Overview
Currently, No data available
---